Segment & Geographic Data
Quant-Grade Normalized (live API)
API & CSV Delivery
Avita Medical Inc's Business Segments
Avita Medical Inc's reported revenue by business segment and by geographic region, quarterly and annual, normalized against the consolidated income statement. Free below: the top 3 rows per table, this quarter and this fiscal year. Subscriber access adds the full segment history and operating income by segment.
Segment Data As of FY
Reportable Segments
7
Largest Segment
US
Total Revenue
$ 22
Countrys Reported
4
Revenue Share by Reportable Segment - FY
- US0%
- Recell System0%
- Recell Go Preparation Kit92.2%
- Cohealyx14.9%
- PermeaDerm4.8%
- JP3.8%
- United Kingdom1.8%
Revenue by Reportable Segment - FY
| Segment | Revenue (Millions) | % of Total |
|---|---|---|
| US | $ 39 | - |
| Recell System | $ 36 | - |
| Recell Go Preparation Kit | $ 20 | 92.2% |
4 more segments available
Sign in to unlock the full Avita Medical Inc dataset.
Revenue Share by Country - FY
- US96.5%
- JP2.3%
- GB1%
- AU0.2%
Revenue by Geographic Country - FY
| Country | Revenue (Millions) | % of Total |
|---|---|---|
| US | $ 19 | 96.5% |
| JP | $ 0 | 2.3% |
| GB | $ 0 | 1% |
1 more countrys available
Sign in to unlock the full Avita Medical Inc dataset.
Revenue by Product & Service Category - FY
- Recell System88.9%
- Recell Go Preparation Kit48.8%
- Other Wound Care Products10.1%
- Lease Revenue1%
Revenue by Product & Service Category - FY
| Category | Revenue (Millions) | % of Total |
|---|---|---|
| Recell System | $ 17 | 88.9% |
| Recell Go Preparation Kit | $ 9 | 48.8% |
| Other Wound Care Products | $ 2 | 10.1% |
Product and service categories are a supplemental disclosure and are not required to sum to consolidated revenue or to the reportable segments above.
1 more categories available
Sign in to unlock the full Avita Medical Inc dataset.
Annual Results
Revenue Share by Reportable Segment - FY
- US0%
- Recell System0%
- Recell Go Preparation Kit92.2%
- Cohealyx14.9%
- PermeaDerm4.8%
- JP3.8%
- United Kingdom1.8%
Revenue by Reportable Segment - FY
| Segment | Revenue (Millions) | % of Total |
|---|---|---|
| US | $ 39 | - |
| Recell System | $ 36 | - |
| Recell Go Preparation Kit | $ 20 | 92.2% |
4 more segments available
Sign in to unlock the full Avita Medical Inc dataset.
Revenue by Product & Service Category - FY
- PermeaDerm8.4%
Revenue by Product & Service Category - FY
| Category | Revenue (Millions) | % of Total |
|---|---|---|
| PermeaDerm | $ 6 | 8.4% |
Product and service categories are a supplemental disclosure and are not required to sum to consolidated revenue or to the reportable segments above.
Description of Avita Medical Inc
Avita Medical Inc. is a global regenerative medicine company that specializes in developing and commercializing innovative solutions for wound care and skin regeneration. The company was founded in 1990 and is headquartered in Melbourne, Australia, with offices in the United States and the United Kingdom.
Avita Medical's main product is the ReCell Autologous Cell Harvesting Device, which allows healthcare professionals to create a regenerative epithelial suspension (RES) from a small sample of the patient's own skin. This RES includes potent skin cells that have the ability to promote healing and regeneration. The RES can then be directly sprayed or placed onto the patient's wound, promoting faster healing and reducing scarring.
The ReCell device offers a significant advancement in the field of wound care as it provides a quick and effective solution for acute injuries, chronic wounds, and severe burns. The device is portable, easy to use, and takes less time than traditional methods of harvesting and processing skin cells. It has been proven to enhance healing outcomes across a wide range of medical applications.
Avita Medical's technology has been supported by extensive clinical research with numerous studies and trials conducted to demonstrate its safety and efficacy. The company has obtained regulatory approvals in multiple markets, including the United States, Europe, Australia, and China.
Apart from wound care, Avita Medical is also exploring other potential applications for its regenerative medicine technology. These include scar management, dermatology, plastic and reconstructive surgery, and even the regeneration of organs and tissues.
In addition to the ReCell device, Avita Medical also offers a range of skin grafting products and accessories that complement its regenerative technology. These products are designed to improve the efficiency and effectiveness of the wound healing process.
Avita Medical is committed to innovation and ongoing research and development to further advance the field of regenerative medicine. The company works closely with leading medical institutions and healthcare professionals to continually improve its products and expand their applications.
Overall, Avita Medical Inc. is a pioneering company at the forefront of regenerative medicine, providing innovative solutions and technologies that improve patient outcomes and quality of life. With its ReCell device and commitment to research and development, Avita Medical continues to revolutionize wound care and skin regeneration.
Avita Medical's main product is the ReCell Autologous Cell Harvesting Device, which allows healthcare professionals to create a regenerative epithelial suspension (RES) from a small sample of the patient's own skin. This RES includes potent skin cells that have the ability to promote healing and regeneration. The RES can then be directly sprayed or placed onto the patient's wound, promoting faster healing and reducing scarring.
The ReCell device offers a significant advancement in the field of wound care as it provides a quick and effective solution for acute injuries, chronic wounds, and severe burns. The device is portable, easy to use, and takes less time than traditional methods of harvesting and processing skin cells. It has been proven to enhance healing outcomes across a wide range of medical applications.
Avita Medical's technology has been supported by extensive clinical research with numerous studies and trials conducted to demonstrate its safety and efficacy. The company has obtained regulatory approvals in multiple markets, including the United States, Europe, Australia, and China.
Apart from wound care, Avita Medical is also exploring other potential applications for its regenerative medicine technology. These include scar management, dermatology, plastic and reconstructive surgery, and even the regeneration of organs and tissues.
In addition to the ReCell device, Avita Medical also offers a range of skin grafting products and accessories that complement its regenerative technology. These products are designed to improve the efficiency and effectiveness of the wound healing process.
Avita Medical is committed to innovation and ongoing research and development to further advance the field of regenerative medicine. The company works closely with leading medical institutions and healthcare professionals to continually improve its products and expand their applications.
Overall, Avita Medical Inc. is a pioneering company at the forefront of regenerative medicine, providing innovative solutions and technologies that improve patient outcomes and quality of life. With its ReCell device and commitment to research and development, Avita Medical continues to revolutionize wound care and skin regeneration.
Avita Medical Inc. is a biotechnology company that focuses on developing and commercializing regenerative medicine products. Their primary aim is to offer innovative solutions for wound care and scar management. Below is an extensive description of the segments, products, and services offered by Avita Medical.
Segments
1. Wound Care
- Avita Medical primarily operates in the wound care segment, addressing conditions such as chronic and acute wounds. This includes diabetic ulcers, pressure ulcers, venous ulcers, and surgical wounds. The company emphasizes the need for effective treatments that enhance healing and reduce complications associated with these injuries.
2. Scar Management
- Another critical segment for Avita Medical involves products aimed at improving outcomes in scar management. This includes both hypertrophic scars and keloids that may result from various injuries or surgical procedures. The company’s innovative solutions aim to reduce the size, appearance, and discomfort typically associated with scars.
3. Regenerative Medicine
- Avita Medical is at the forefront of regenerative medicine, focusing on therapies that harness the body’s inherent healing mechanisms. By promoting tissue regeneration and repair, their products aim to provide a more natural healing process compared to traditional treatments.
Products
1. RECELL® System
- The RECELL® System is Avita Medicals flagship product, designed to treat wounds and scars. It utilizes a unique process that involves harvesting a small amount of skin from a patient, which is then processed to create a suspension of viable cells. This suspension can be applied directly to the wound or scar, promoting faster healing and improved aesthetic outcomes.
- The RECELL® System is FDA-approved and has received widespread endorsement due to its innovative approach to wound healing. It is used in various clinical settings, including hospitals and specialized dermatology clinics.
2. Product Applications
- The RECELL® System is indicated for use in a range of applications, including:
- Burn Treatment: Effective for acute burn wounds, allowing for rapid coverage and healing.
- Chronic Wound Management: Applied in difficult-to-heal wounds, such as diabetic foot ulcers and venous stasis ulcers.
- Scar Treatment: Used to address hypertrophic scars and keloids, focusing on both functional and cosmetic outcomes.
3. Investigational Products
- Avita Medical has a pipeline of investigational products currently under development. These may include extensions of the RECELL® technology for additional indications, such as other types of difficult-to-heal wounds or novel applications in regenerative medicine.
Services
1. Training and Support
- Avita Medical provides comprehensive training programs for healthcare professionals. This includes workshops, webinars, and in-service training sessions designed to educate clinicians on the proper use of the RECELL® System and best practices in wound management.
- Ongoing customer support is also a critical component, ensuring that medical personnel can effectively integrate Avita’s products into their treatment protocols.
2. Clinical Research and Collaborations
- Avita Medical actively engages in clinical research to validate the efficacy and safety of their products. This includes collaborations with hospitals, universities, and research institutions to conduct studies that contribute to the scientific understanding of regenerative medicine.
- The company may also participate in clinical trials to explore new applications of their existing technologies and push the boundaries of wound care practices.
3. Regulatory and Compliance Assistance
- Given the stringent regulatory environment in the biotechnology and medical device sectors, Avita Medical offers support to healthcare providers in navigating compliance issues related to the use of their products. This includes providing guidance on documentation, billing, and insurance reimbursement processes.
Conclusion
Avita Medical Inc. is a pioneering company in the fields of wound care, scar management, and regenerative medicine. They offer innovative products like the RECELL® System and provide extensive training and support services for healthcare professionals. Through their commitment to research and collaboration, Avita Medical continues to advance the field of wound healing and improve the quality of care available to patients suffering from complex wounds and scars.
Segments
1. Wound Care
- Avita Medical primarily operates in the wound care segment, addressing conditions such as chronic and acute wounds. This includes diabetic ulcers, pressure ulcers, venous ulcers, and surgical wounds. The company emphasizes the need for effective treatments that enhance healing and reduce complications associated with these injuries.
2. Scar Management
- Another critical segment for Avita Medical involves products aimed at improving outcomes in scar management. This includes both hypertrophic scars and keloids that may result from various injuries or surgical procedures. The company’s innovative solutions aim to reduce the size, appearance, and discomfort typically associated with scars.
3. Regenerative Medicine
- Avita Medical is at the forefront of regenerative medicine, focusing on therapies that harness the body’s inherent healing mechanisms. By promoting tissue regeneration and repair, their products aim to provide a more natural healing process compared to traditional treatments.
Products
1. RECELL® System
- The RECELL® System is Avita Medicals flagship product, designed to treat wounds and scars. It utilizes a unique process that involves harvesting a small amount of skin from a patient, which is then processed to create a suspension of viable cells. This suspension can be applied directly to the wound or scar, promoting faster healing and improved aesthetic outcomes.
- The RECELL® System is FDA-approved and has received widespread endorsement due to its innovative approach to wound healing. It is used in various clinical settings, including hospitals and specialized dermatology clinics.
2. Product Applications
- The RECELL® System is indicated for use in a range of applications, including:
- Burn Treatment: Effective for acute burn wounds, allowing for rapid coverage and healing.
- Chronic Wound Management: Applied in difficult-to-heal wounds, such as diabetic foot ulcers and venous stasis ulcers.
- Scar Treatment: Used to address hypertrophic scars and keloids, focusing on both functional and cosmetic outcomes.
3. Investigational Products
- Avita Medical has a pipeline of investigational products currently under development. These may include extensions of the RECELL® technology for additional indications, such as other types of difficult-to-heal wounds or novel applications in regenerative medicine.
Services
1. Training and Support
- Avita Medical provides comprehensive training programs for healthcare professionals. This includes workshops, webinars, and in-service training sessions designed to educate clinicians on the proper use of the RECELL® System and best practices in wound management.
- Ongoing customer support is also a critical component, ensuring that medical personnel can effectively integrate Avita’s products into their treatment protocols.
2. Clinical Research and Collaborations
- Avita Medical actively engages in clinical research to validate the efficacy and safety of their products. This includes collaborations with hospitals, universities, and research institutions to conduct studies that contribute to the scientific understanding of regenerative medicine.
- The company may also participate in clinical trials to explore new applications of their existing technologies and push the boundaries of wound care practices.
3. Regulatory and Compliance Assistance
- Given the stringent regulatory environment in the biotechnology and medical device sectors, Avita Medical offers support to healthcare providers in navigating compliance issues related to the use of their products. This includes providing guidance on documentation, billing, and insurance reimbursement processes.
Conclusion
Avita Medical Inc. is a pioneering company in the fields of wound care, scar management, and regenerative medicine. They offer innovative products like the RECELL® System and provide extensive training and support services for healthcare professionals. Through their commitment to research and collaboration, Avita Medical continues to advance the field of wound healing and improve the quality of care available to patients suffering from complex wounds and scars.